IL6 and tuberculosis: Conversely, patients with cavitary TB—a severe form of pulmonary disease—were found to exhibit a reduced content of IL-6 in the bronchoalveolar lavage (BAL) in comparison to TB patients without cavities, suggesting the cytokine as a potential biomarker for protection against tissue destruction during advanced TB [165].